FMT
VNDA icon

First Mercantile Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

First Mercantile Trust’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,845
Closed -$50K – 966
2020
Q1 		$50K Sell
4,845
-34
-0.7% -$422 0.01% 704
2019
Q4 		$80K Sell
4,879
-81
-2% -$1.23K 0.01% 731
2019
Q3 		$66K Buy
4,960
+516
+12% +$7.19K 0.01% 773
2019
Q2 		$63K Buy
4,444
+84
+2% +$1.34K 0.01% 734
2019
Q1 		$80K Sell
4,360
-750
-15% -$17.1K 0.02% 718
2018
Q4 		$134K Sell
5,110
-890
-15% -$20.9K 0.03% 555
2018
Q3 		$138K Sell
6,000
-1,195
-17% -$24.4K 0.03% 615
2018
Q2 		$137K Buy
7,195
+335
+5% +$5.6K 0.03% 622
2018
Q1 		$116K Hold
6,860
– – 0.02% 648
2017
Q4 		$104K Buy
6,860
+880
+15% +$13.1K 0.02% 706
2017
Q3 		$107K Sell
5,980
-50
-0.8% -$837 0.02% 706
2017
Q2 		$98K Sell
6,030
-100
-2% -$1.44K 0.02% 732
2017
Q1 		$86K Sell
6,130
-360
-6% -$5.13K 0.01% 761
2016
Q4 		$104K Buy
6,490
+70
+1% +$1.13K 0.02% 746
2016
Q3 		$107K Sell
6,420
-2,440
-28% -$32.8K 0.01% 711
2016
Q2 		$99K Sell
8,860
-290
-3% -$2.81K 0.01% 740
2016
Q1 		$76K Sell
9,150
-300
-3% -$2.46K 0.01% 791
2015
Q4 		$88K Buy
9,450
+240
+3% +$2.4K 0.01% 843
2015
Q3 		$104K Buy
9,210
+1,620
+21% +$19.8K 0.01% 813
2015
Q2 		$96K Sell
7,590
-110
-1% -$1.19K 0.01% 878
2015
Q1 		$72K Buy
+7,700
New +$87K 0.01% 910
2014
Q3 		– Sell
-3,505
Closed -$57K – 1205
2014
Q2 		$57K Buy
+3,505
New +$46.7K ﹤0.01% 928

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

First Mercantile Trust's VNDA Position: Q2 2020 in Review

First Mercantile Trust sold out of Vanda Pharmaceuticals (VNDA) in Q2 2020, closing a stake of 4,845 shares — an estimated $50K sold.

First Mercantile Trust first reported a position in VNDA in Q2 2014 and held it in 22 quarters. The position peaked at $138K in Q3 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2020.

  • First Mercantile Trust reported no remaining Vanda Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • First Mercantile Trust sold 4,845 Vanda Pharmaceuticals shares in Q2 2020, an estimated $50K.
  • First Mercantile Trust first reported a position in Vanda Pharmaceuticals in Q2 2014 and held it in 22 quarters.
  • First Mercantile Trust's Vanda Pharmaceuticals position peaked at $138K in Q3 2018.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.